As of 2025-12-27, the EV/EBITDA ratio of Treace Medical Concepts Inc (TMCI) is -5.36. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TMCI's latest enterprise value is 203.12 mil USD. TMCI's TTM EBITDA according to its financial statements is -37.92 mil USD. Dividing these 2 quantities gives us the above TMCI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 18.8x - 23.6x | 21.0x |
| Forward P/E multiples | 23.2x - 27.1x | 25.6x |
| Fair Price | (14.55) - (14.78) | (14.61) |
| Upside | -696.5% - -705.8% | -698.9% |
| Date | EV/EBITDA |
| 2025-12-24 | -5.36 |
| 2025-12-23 | -5.26 |
| 2025-12-22 | -5.42 |
| 2025-12-19 | -5.57 |
| 2025-12-18 | -5.44 |
| 2025-12-17 | -5.59 |
| 2025-12-16 | -5.79 |
| 2025-12-15 | -5.91 |
| 2025-12-12 | -5.96 |
| 2025-12-11 | -6.15 |
| 2025-12-10 | -6.06 |
| 2025-12-09 | -5.93 |
| 2025-12-08 | -5.64 |
| 2025-12-05 | -5.86 |
| 2025-12-04 | -5.86 |
| 2025-12-03 | -5.76 |
| 2025-12-02 | -5.79 |
| 2025-12-01 | -6.01 |
| 2025-11-28 | -6.26 |
| 2025-11-26 | -6.31 |
| 2025-11-25 | -6.45 |
| 2025-11-24 | -6.18 |
| 2025-11-21 | -6.06 |
| 2025-11-20 | -5.64 |
| 2025-11-19 | -5.83 |
| 2025-11-18 | -5.94 |
| 2025-11-17 | -6.11 |
| 2025-11-14 | -6.35 |
| 2025-11-13 | -6.53 |
| 2025-11-12 | -6.84 |
| 2025-11-11 | -6.90 |
| 2025-11-10 | -7.24 |
| 2025-11-07 | -8.76 |
| 2025-11-06 | -11.72 |
| 2025-11-05 | -11.76 |
| 2025-11-04 | -12.21 |
| 2025-11-03 | -12.33 |
| 2025-10-31 | -11.99 |
| 2025-10-30 | -11.93 |
| 2025-10-29 | -12.26 |
| 2025-10-28 | -12.75 |
| 2025-10-27 | -12.77 |
| 2025-10-24 | -12.80 |
| 2025-10-23 | -12.67 |
| 2025-10-22 | -12.78 |
| 2025-10-21 | -12.93 |
| 2025-10-20 | -12.68 |
| 2025-10-17 | -12.08 |
| 2025-10-16 | -11.98 |
| 2025-10-15 | -11.54 |